Src inhibition has already been demonstrated as an effective antimetastatic therapy in MM231 cells57,58, and recent work has found similar efficacy for SHP099 in reducing lung colonization by mouse 4T1 breast cancer cells59. This evidence concerns the gene SRC and breast carcinoma.